International Journal of Drug Policy
Volume 12, Issue 5 , Pages 469-475 , 1 November 2001

What to do about “much ado” about drug courts?

  • John F Anderson

      Affiliations

    • Corresponding Author InformationPresent address: Clinical Support Unit, 1520 Blanshard Street, 3rd Floor, Victoria, BC, Canada V8W 3C8. Tel.: +1-250-952-2301; fax: +1-250-952-3225

Received 8 May 2001 ,Accepted 10 September 2001.

References 

  1. Belenko S. Research on drug courts: a critical review. National Drug Court Institute Review. 1998;I(1):1–43
  2. Belenko S. (1998b), Behind bars: Substance abuse and America's prison population (New York: The National Center on Addiction and Substance Abuse).
  3. Belenko S. (2000), Research on drug courts: a critical review 2001 update (New York: The National Center on Addiction and Substance Abuse).
  4. Belenko S. (2001), Research on drug courts: a critical review 2001 update (New York: The National Center on Addiction and Substance Abuse).
  5. Ferrini R. American College of Preventive Medicine public policy on needle-exchange programs to reduce drug-associated morbidity and mortality. American Journal of Preventive Medicine. 2000;XVIII(2):173–175
  6. Freeman K, Lawrence Karski R, Doak P. (2000), New South Wales drug court evaluation: program and participant profiles (Sydney, Australia: Bureau of Crime statistics and Research).
  7. Gliksman L, La Prairie C, Erickson P, et al. (2000), The Toronto Drug Treatment Court: a one-year summary: December 1, 1998–December 31, 1999 (Toronto: Centre for Addiction and Mental Health).
  8. Goldkamp JS, White MD, Robinson JB, et al.  Do drug courts work? Getting inside the drug court black box. Journal of Drug Issues. 2001;XXXI(1):27–72
  9. Gossop M, Marsden J, Stewart D. (1996), NTORS-At One Year. The National Treatment Outcome Research Study: changes in substance use, health and criminal behaviour one year after intake (Wetherby, UK: Department of Health).
  10. Government of Canada (2000), Toronto drug treatment court update (Ottawa: National Crime Prevention Centre).
  11. Harrell A, Cavanagh S, Roman J. (1998), Findings from the evaluation of the D.C. Superior Court drug intervention program: final report (Washington, DC: The Urban Institute).
  12. Hubbard RL, Craddock SG, Flynn PM, et al.  Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;XI(4):261–278
  13. Lewis DC. (1999), ‘Drug courts are popular—will they be good?’ Commentary in DATA: Brown University Digest of Addiction Theory and Application, May issue.
  14. Lurie S. Addiction medicine specialists add a new therapeutic approach. Journal of the American Medical Association. 2000;CCLXXXIII(20):2644–2645
  15. Office of the Director (1997), Effective medical treatment of opiate addiction: NIH consensus statement, 15(6):1–38 (Kensington, MD: National Institutes of Health).
  16. Peters RH and Murrin MR (1998), Evaluation of treatment-based drug courts in Florida's First Judicial Circuit (Tampa, FL: University of South Florida).
  17. Peters RH, Haas AL, Murrin MR. Predictors of retention and arrest in drug courts. National Drug Court Institute Review. 1999;II(1):30–48
  18. Police Services Division. (1999), Crime Statistics (Victoria: BC. Ministry of the Attorney General).
  19. Tauber JJ, Snavely KR. (1999), Drug courts: a research agenda (Alexandria, VA: National Drug Court Institute).
  20. Truitt L, Rhodes WM, Seeherman AM, et al. (2000) Impact evaluations of Pensacola and Kansas City drug court programs (Cambridge, MA: Abt Associates Inc.).
  21. United States General Accounting Office (1997), Drug courts: overview of growth, characteristics, and results (Washington, DC: United States General Accounting Office).
  22. van Ameijden EJC, Langendam MW, Coutinho RA. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addictive Behaviours. 1999;XXIV(4):559–563
  23. Zaric GS, Barnett PG, Brandeau ML. HIV Transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health. 2000;XC(7):1100–1111

PII: S0955-3959(01)00109-8

International Journal of Drug Policy
Volume 12, Issue 5 , Pages 469-475 , 1 November 2001